{
  "ticker": "LLY",
  "target_date": "2024-12-31",
  "actual_date": "2024-12-31",
  "collected_at": "2025-12-08T11:13:00.296175",
  "price": {
    "open": 765.29,
    "high": 768.18,
    "low": 758.64,
    "close": 766.2843627929688,
    "volume": 2327000,
    "change_1d_pct": -0.24,
    "change_7d_pct": 1.91,
    "change_30d_pct": 3.46
  },
  "technicals": {
    "rsi_14": 38.37,
    "sma_20": 785.58,
    "sma_50": 799.01,
    "macd": -7.072,
    "macd_signal": -7.628,
    "macd_histogram": 0.556,
    "bb_upper": 826.92,
    "bb_lower": 744.25,
    "price_vs_sma20_pct": -2.46,
    "price_vs_sma50_pct": -4.1,
    "volume_ratio": 0.72
  },
  "fundamentals": {
    "market_cap": 890740080640,
    "pe_ratio": 48.683144,
    "forward_pe": 43.849205,
    "price_to_book": 37.410503,
    "price_to_sales": 14.990627,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.64,
    "pct_from_52w_low": 59.29
  },
  "macro": {
    "spy": {
      "price": 580.99,
      "change_1d_pct": -0.36,
      "change_7d_pct": -0.86
    },
    "vix": {
      "level": 17.35,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.57
    },
    "dollar_index": {
      "level": 108.49
    },
    "gold": {
      "price": 2629.2
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "GLP-1 questions emerge for 2025",
      "source": "Yahoo",
      "datetime": 1735681738,
      "summary": "The 2025 outlook for GLP-1s isn't as bullish as it once was, but all hope is not lost.",
      "url": "https://finnhub.io/api/news?id=10d16fd7419a29a826adae343cff42b8cce630ca6029cd6b54f4057e9d8f8745"
    },
    {
      "headline": "Novo Nordisk A/S (NVO): A Bull Case Theory",
      "source": "Yahoo",
      "datetime": 1735664520,
      "summary": "We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments\u2019 Substack by Kontra. In this article, we will summarize the bulls\u2019 thesis on NVO. Novo Nordisk A/S (NYSE:NVO)\u2019s share was trading at $85.73 as of Dec 30th. NVO\u2019s trailing and forward P/E were 28.92 and 21.98 respect",
      "url": "https://finnhub.io/api/news?id=e96fa6f191b6b55ba39ac253c65b25e372610af0f58d41db52024e908bde36ea"
    },
    {
      "headline": "Lilly and Novo Went Head-to-Head Over Weight-Loss Drugs in 2024. There\u2019s a Clear Winner.",
      "source": "Yahoo",
      "datetime": 1735656720,
      "summary": "It hasn\u2019t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.",
      "url": "https://finnhub.io/api/news?id=1d241cb1ecdcc9bff0c0cc72f2284de5f6a474d0c3114f9ee312c1093cacf838"
    },
    {
      "headline": "Akero Therapeutics: Where This Potential MASH Play Stands Currently",
      "source": "SeekingAlpha",
      "datetime": 1735649392,
      "summary": "Discover the latest on Akero Therapeutics, Inc., a biotech firm focusing on metabolic balance therapies, with a market cap of $2 billion. Click for my AKRO update.",
      "url": "https://finnhub.io/api/news?id=59f1490761432441566bcb1c76e1b8ca8e84060130f68c53918f19c2e06d32c5"
    },
    {
      "headline": "Is Eli Lilly and Company (LLY) the Best Low Volatility Stock to Buy Right Now?",
      "source": "Yahoo",
      "datetime": 1735644621,
      "summary": "We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best low volatility stocks to buy right now. The market has shown strong performance overall, with the S&P 500 up",
      "url": "https://finnhub.io/api/news?id=85206a8b7c71e91d0c1d887f3c4cc53bd2d467d9671f123f7a09db131cd16404"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470584.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/xslF345X05/wk-form4_1734470584.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470498.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/xslF345X05/wk-form4_1734470498.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470366.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/xslF345X05/wk-form4_1734470366.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470270.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/xslF345X05/wk-form4_1734470270.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470180.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000283/xslF345X05/wk-form4_1734470180.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}